NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · IEX Real-Time Price · USD
0.858
-0.020 (-2.29%)
At close: Jul 19, 2024, 4:00 PM
0.950
+0.092 (10.72%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
NMTC Revenue
NeuroOne Medical Technologies had revenue of $3.73M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $1.38M with 195.45% year-over-year growth. In the fiscal year ending September 30, 2023, NeuroOne Medical Technologies had annual revenue of $3.41M with 60.73% growth.
Revenue (ttm)
$3.73M
Revenue Growth
-8.64%
P/S Ratio
6.41
Revenue / Employee
$232,914
Employees
16
Market Cap
23.89M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
Sep 30, 2020 | 1.93M | - | - |
Sep 30, 2019 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Akso Health Group | 2.20M |
HCW Biologics | 1.16M |
Femasys | 1.05M |
Can-Fite BioPharma | 743.00K |
Biora Therapeutics | 544.00K |
NMTC News
- 4 weeks ago - NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation - GlobeNewsWire
- 2 months ago - NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14 - GlobeNewsWire
- 3 months ago - NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology - GlobeNewsWire
- 3 months ago - NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes - GlobeNewsWire
- 3 months ago - NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co. - GlobeNewsWire
- 4 months ago - NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System - GlobeNewsWire
- 4 months ago - NeuroOne® to Participate in the 36th Annual Roth Conference - GlobeNewsWire